Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404101 · ClinicalTrials.gov registry record · NA
Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
A NA study of Pancreatic Cyst, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT04404101 is a NA study of Pancreatic Cyst that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 300 participants, below the 534-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target (44% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04404101, a NA study of Pancreatic Cyst, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
Pancreatic cystic lesions (PCLs) are a common incidental finding in cross sectional imaging (up to 27% on CT scan and 41% on MRI) and pose a management challenge to physicians. According to society guidelines, PCLs with specific features should prompt additional workup with endoscopic ultrasound (EUS) for cyst characterization as well as cyst sampling. This can help determine if the cyst is mucinous or non-mucinous which has implications for its malignant potential. Cyst fluid has traditionally been sampled using EUS with fine needle aspiration (EUS-FNA) and sent for fluid analysis and cytology. More recently, the adjunctive use of the through-the-scope micro forceps (Moray micro forceps, US Endoscopy, Mentor, OH) biopsy (EUS-MFB) has shown promise for diagnosis of PCLs. This technology utilizes a micro forceps through a 19-gauge needle to biopsy the cyst wall for histology, in addition to collecting cyst fluid for CEA level and cytology. More recently, the adjunctive use of the Moray® through the needle micro forceps biopsy (EUS-MFB) has shown promise for diagnosis of PCLs. This technology utilizes a micro forceps through a 19-gauge needle to biopsy the cyst wall for histology, in addition to collecting cyst fluid for CEA level and cytology. Only a few small retrospective reports have been published regarding the use of MFB. The results of this study will hopefully help increase diagnostic yield by obtaining a histopathologic diagnosis of these PCLs, and potentially affect practice patterns of gastroenterologists and the endoscopic community, specifically those physicians who perform EUS in these patients. Furthermore, the results will help determine whether there is reason to continue this line of research to obtain a definite histologic tissue diagnosis of PCLs.
Conditions Studied
Interventions
- PROCEDURE 1). EUS-FNA plus MFB
- PROCEDURE 2). EUS-FNA Alone
Study Locations (3)
California
- University of California Irvine - Irvine
Colorado
- University of Colorado - Anschutz Medical Campus - Aurora
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-05-11 |
| Est. Completion | 2025-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04404101
The ClinicalTrials.gov registry entry for NCT04404101 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 534-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target (44% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Cyst appearing as the primary indexed condition, and to 2 interventions - of which 1). EUS-FNA plus MFB is the first listed.
NCT04404101 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Colorado, Texas.
Frequently Asked Questions
What is clinical trial NCT04404101 about?
NCT04404101 is a clinical study titled "Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies". Pancreatic cystic lesions (PCLs) are a common incidental finding in cross sectional imaging (up to 27% on CT scan and 41% on MRI) and pose a management challenge to physicians. According to society guidelines, PCLs with specific features should prompt additional workup with endoscopic ultrasound (EU...
What is the current status of trial NCT04404101?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-05-11. Estimated completion is 2025-04.
What conditions does trial NCT04404101 study?
This clinical trial studies the following conditions: Pancreatic Cyst.
What interventions are being tested in trial NCT04404101?
The interventions under investigation include: 1). EUS-FNA plus MFB (PROCEDURE), 2). EUS-FNA Alone (PROCEDURE).
Who is sponsoring clinical trial NCT04404101?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04404101 being conducted?
This trial has 3 study locations across California, Colorado, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cyst
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts
COMPLETED · NA
-
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
COMPLETED · NA
-
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
RECRUITING
-
UCSF PANC Cyst Registry
RECRUITING
-
PROMs After Pancreatectomy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.